Roth Capital Downgrades Catalyst Pharmaceutical Partners (CPRX) to Neutral
Tweet Send to a Friend
Roth Capital analyst Scott Henry downgraded Catalyst Pharmaceutical Partners (NASDAQ: CPRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
